Synthesis and structure reassignment of mercaptohistidines of marine origin. Syntheses of L-ovothiols A and C

DOI: 10.1021/jo00228a060

Source and publish data:

Journal of Organic Chemistry p. 4420 - 4421 (1987)

Update date:2022-07-30

Topics: Synthesis

Authors:

Piers Piers

Skerlj Skerlj

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/jo00228a060

Full text of DOI:10.1021/jo00228a060

Products guided by the article

Product name:(S)-(4-methoxyphenyl)methyl-L-ovothiol C

Cas No:110117-74-3

R&D Labs maybe for 110117-74-3

Oceachem Group Limited

website:http://www.oceanchem-group.com

Contact:86-536-8596048

Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Langchem

Contact:+86+21-58956006 15800617331

Address:402 Room, 150# Cailun Road, Zhangjiang high tech park, Shanghai
ShangHai Soyoung Biotechnology Inc

website:http://www.soyoungbio.com

Contact:+86-21-69893009

Address:shanghai
Xi'an Unique Electronic and Chemical Co., Ltd.

Contact:+86-029-88238008

Address:1703# B BUILDING WEST ELECTRONIC ZONE, XI'AN, CHINA
BrightGene Bio-Medical Technology Co., Ltd.

website:https://en.bright-gene.com/

Contact:+86-512-62551801

Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.

Relevant to this article

Doi:10.1021/ja01608a030
(1955)
CHEMICAL STUDIES OF 10-DEACETYL BACCATIN III. HEMISYNTHESIS OF TAXOL DERIVATIVES.

Doi:10.1016/S0040-4020(01)87285-9
(1986)
Total synthesis and NMR investigations of cylindramide

Doi:10.1002/chem.200501274
(2006)
Use of Diethylaminosulphur Trifluoride (DAST) in the Preparation of Synthons of Carbocyclic Nucleosides

Doi:10.1039/P19880000549
(1988)
Plant antitumor agents. 28. Resolution of a key tricyclic synthon, 5'(RS)-1,5-dioxo-5'-ethyl-5'-hydroxy-2'H,5'H,6'H,H-6'-oxopyrano[3',4' f]Δ^6,8-tetrahydroindolizine: Total synthesis and antitumor activity of 20(S)- and 20(R)-camptothecin

Doi:10.1021/jm00395a024
(1987)
Click chelators for platinum-based anticancer drugs

Doi:10.1002/ejic.200700849
(2008)

Article Doi